| 06/10/2026 3:09 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 12:12 PM | Cormorant Asset Management, LP (1583977) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 05/14/2026 9:30 AM | BML Investment Partners, L.P. (1373604) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 05/13/2026 8:23 PM | BML Investment Partners, L.P. (1373604) Filed by enGene (1980845) Subject | Form SCHEDULE 13G | |
| 05/08/2026 3:06 PM | enGene (1980845) Filer | Form DEF 14A | |
| 05/07/2026 6:11 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/05/2026 9:59 AM | enGene (1980845) Subject Invus Global Management, LLC (2005369) Filed by | Form SCHEDULE 13G/A | |
| 04/09/2026 3:02 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/09/2026 11:20 AM | enGene (1980845) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/09/2026 6:25 AM | enGene (1980845) Filer | Form 424B5 | |
| 03/09/2026 6:09 AM | enGene (1980845) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for ENGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for enGene and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/09/2026 6:15 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/09/2026 6:04 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/02/2026 11:15 PM | enGene (1980845) Filer | Form EFFECT | |
| 02/19/2026 3:25 PM | enGene (1980845) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 02/17/2026 5:09 PM | enGene (1980845) Subject Venrock Healthcare Capital Partners III, L.P. (1738048) Filed by | Form SCHEDULE 13G/A | |
| 02/17/2026 2:00 PM | Cormorant Asset Management, LP (1583977) Filed by enGene (1980845) Subject | Form SCHEDULE 13G | |
| 02/17/2026 11:46 AM | enGene (1980845) Subject Kynam Capital Management, LP (1907884) Filed by | Form SCHEDULE 13G/A | |
| 01/27/2026 1:18 PM | enGene (1980845) Subject Invus Global Management, LLC (2005369) Filed by | Form SCHEDULE 13G | |
| 01/21/2026 6:38 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/22/2025 3:11 PM | enGene (1980845) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 12/22/2025 3:04 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 7:12 AM | Deep Track Capital, LP (1856083) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 11/14/2025 6:01 AM | enGene (1980845) Filer | Form 424B5 | |
| 11/12/2025 5:16 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/30/2025 6:36 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/11/2025 3:44 PM | enGene (1980845) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 09/11/2025 3:08 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/11/2025 3:11 PM | enGene (1980845) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 09/03/2025 6:56 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/14/2025 3:09 PM | Boyd Matthew Ross (2077001) Reporting enGene (1980845) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/14/2025 3:10 PM | Boyd Matthew Ross (2077001) Reporting enGene (1980845) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/08/2025 3:10 PM | enGene (1980845) Issuer Grossman William (1730229) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 07/08/2025 3:11 PM | Astley-Sparke Philip (1376491) Reporting enGene (1980845) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/08/2025 3:13 PM | enGene (1980845) Issuer Heffernan Michael Thomas (1448914) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 07/08/2025 3:08 PM | Buck Jill (1780426) Reporting enGene (1980845) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/08/2025 7:09 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/16/2025 5:36 PM | Bos Jasper (1897789) Reporting enGene (1980845) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 5:37 PM | BRUNK GERALD A (1380226) Reporting enGene (1980845) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 5:38 PM | enGene (1980845) Issuer Glickman Richard M (1352637) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 5:38 PM | enGene (1980845) Issuer HASTINGS PAUL J (1309702) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
SpaceX is offering you shares. Don't take them. (Ad) SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. But at a $1.75 trillion valuation and 266 times earnings, early institutional holders may be looking for someone to sell to.
Dylan Jovine has identified a small company in Musk's supply chain that builds the power infrastructure behind Colossus - still trading at a fraction of its potential value. No IPO allocation required. Get the backdoor ticker free before the SpaceX IPO launches |
| 06/16/2025 5:39 PM | enGene (1980845) Issuer Joustra Wouter (1897813) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 5:40 PM | enGene (1980845) Issuer Pott Amy (1787363) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 5:40 PM | enGene (1980845) Issuer Zoth Lota S. (1278219) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 7:05 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/12/2025 7:08 AM | enGene (1980845) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 06/10/2025 4:26 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |